IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 83 filers reported holding IMMUNOMEDICS INC in Q3 2013. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,222,000 | +15.3% | 188,900 | -34.6% | 0.02% | +7.1% |
Q4 2016 | $1,060,000 | +12.9% | 288,900 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $939,000 | +40.1% | 288,900 | 0.0% | 0.01% | +40.0% |
Q2 2016 | $670,000 | -7.2% | 288,900 | 0.0% | 0.01% | -16.7% |
Q1 2016 | $722,000 | -18.6% | 288,900 | 0.0% | 0.01% | -25.0% |
Q4 2015 | $887,000 | +78.5% | 288,900 | 0.0% | 0.02% | +60.0% |
Q3 2015 | $497,000 | -45.1% | 288,900 | +29.6% | 0.01% | -44.4% |
Q2 2015 | $905,000 | +4.9% | 222,900 | -1.1% | 0.02% | 0.0% |
Q1 2015 | $863,000 | -20.2% | 225,300 | 0.0% | 0.02% | -28.0% |
Q4 2014 | $1,081,000 | +29.0% | 225,300 | 0.0% | 0.02% | +19.0% |
Q3 2014 | $838,000 | +1.9% | 225,300 | 0.0% | 0.02% | -4.5% |
Q2 2014 | $822,000 | -13.4% | 225,300 | 0.0% | 0.02% | -18.5% |
Q1 2014 | $949,000 | -8.4% | 225,300 | 0.0% | 0.03% | -15.6% |
Q4 2013 | $1,036,000 | -33.5% | 225,300 | -10.3% | 0.03% | -39.6% |
Q3 2013 | $1,558,000 | +8.4% | 251,300 | -4.8% | 0.05% | -7.0% |
Q2 2013 | $1,437,000 | – | 264,100 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |